“…Eight compounds, 6QH, donepezil (E20), BHT, EGCG, CNS-11, BHT-6QH, BHT-E20, and BHT-CNS-11, were examined, and their structure–activity relationships are summarized in Table 1 . 6QH [ 43 ] and E20 [ 44 ] are known inhibitors of the 3β isoform of glycogen synthase kinase (GSK-3β) and acetylcholinesterase (AChE) and are associated with the hyperphosphorylation of tau and the degradation of acetylcholine in neurons, respectively. Inhibitions of GSK-3β and AChE can disrupt the tau aggregation pathway [ 45 , 46 , 47 ] and improve acetylcholine signaling [ 44 ].…”